Atea Pharmaceuticals's total assets for Q1 2026 were $267.08M, a decrease of -15.27% from the previous quarter. AVIR total liabilities were $33.37M for the fiscal quarter, a -16.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.